What is ArcticZymes Technologies ASA Days Payable?
ArcticZymes Technologies ASALTS:0DRV 77 Days Payable is 215.46 as of Mar. 2026, which is 38% below its 10-year median of 345.68. GuruFocus rates LTS:0DRV with a GF Score™ of 77/100 and a GF Value™ of kr23.85 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 702 Biotechnology companies, ArcticZymes Technologies ASA ranks better than 70.8% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DRV vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Days Payable distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's Days Payable falls into.
ArcticZymes Technologies ASA Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (LTS:0DRV) has a Days Payable of 215.46 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ArcticZymes Technologies ASA and its competitors. This is 38% below median its historical median of 345.68. Over the past decade, ArcticZymes Technologies ASA's Days Payable has ranged from 93.36 to 1,527.43. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #205 out of 702 companies in the Biotechnology industry, placing it in the top 29.2%.
Is ArcticZymes Technologies ASA's Days Payable too high?
ArcticZymes Technologies ASA's current Days Payable of 215.46 is 38% below median its 10-year median of 345.68. Over the past 10 years, this metric has ranged from a low of 93.36 to a high of 1,527.43. The Biotechnology industry median Days Payable is 113.56. ArcticZymes Technologies ASA's value of 215.46 is 89.7% above this industry median. Based on the distribution chart, ArcticZymes Technologies ASA ranks #205 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #205 out of 702 companies for Days Payable. This puts ArcticZymes Technologies ASA in the upper half of its industry. The industry median Days Payable is 113.56. ArcticZymes Technologies ASA's value of 215.46 is 89.7% above this benchmark. Historically, ArcticZymes Technologies ASA's own Days Payable has ranged from 93.36 to 1,527.43 over the past decade. While the company's 10-year median is 345.68 vs. the industry median of 113.56, ArcticZymes Technologies ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ArcticZymes Technologies ASA's current Days Payable of 215.46 is 89.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ArcticZymes Technologies ASA and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current Days Payable is 215.46, which is 38% below median its own 10-year median of 345.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.85, compared to a current price of kr20.90 — trading 12.4% below its estimated fair value. The current Days Payable is 215.46, which is 38% below median its 10-year median of 345.68 and 89.7% above the Biotechnology industry median of 113.56. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Days Payable is 215.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of kr20.90 is trading 12.4% below its estimated GF Value™ of kr23.85.
GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.
Key valuation signals for LTS:0DRV:
Days Payable: 215.46 (38% below median its 10-year median of 345.68)
GF Value™: kr23.85 vs. price of kr20.90 (12.4% below fair value)
Industry Position: 89.7% above the Biotechnology median (#205 of 702)
No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score
Get the complete analysis for LTS:0DRV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRV has been successfully added to your 
